| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/06/2006 | CN1827777A Application of osteopontin inhibitor in rheumatoid arthritis treatment |
| 09/06/2006 | CN1827646A Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/06/2006 | CN1827638A Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 09/06/2006 | CN1827635A Glycopeptide compositions |
| 09/06/2006 | CN1827171A Method for preparing capsaicin carrier |
| 09/06/2006 | CN1827168A Treatment of t cell mediated autoimmune disorders |
| 09/06/2006 | CN1827150A Externally applied emulsion film for treating rheumatic and rheumatoid disease and its preparing method |
| 09/06/2006 | CN1827131A Medicinal composition for treating dysmenorrhea and preparation method thereof |
| 09/06/2006 | CN1827124A Dripping pills of herba lamiophlomis rotatae and method for preparing the same |
| 09/06/2006 | CN1827122A Quality control method of heat-clearing toxin-removing cold-treating honeysuckle injection |
| 09/06/2006 | CN1827113A Pharmaceutical composition with anti-inflammation action |
| 09/06/2006 | CN1827107A Substained analgesia achieved with buprenorphine |
| 09/06/2006 | CN1827094A Gel type dexketoprofen plaster and method for preparing the same |
| 09/06/2006 | CN1273466C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 09/06/2006 | CN1273460C Benzofuran and benzothiophene derivatives |
| 09/06/2006 | CN1273456C Thiazole or oxazole derivatives |
| 09/06/2006 | CN1273454C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/06/2006 | CN1273435C Process for producing ibuprofen microcrystal |
| 09/06/2006 | CN1273195C Carbonized pollen and its application in preparation of cancer-treating medicine |
| 09/06/2006 | CN1273184C Formulation of analgecizing and bone strengthening adhesive plaster and its manufacturing process |
| 09/06/2006 | CN1273178C Chinese medicine composition for treating rheumatoid arthritis |
| 09/06/2006 | CN1273167C Externally-applied medicine for treating rheumatism and its preparation method |
| 09/06/2006 | CN1273145C Use of sodium selenite in producing medicine |
| 09/06/2006 | CN1273137C Compound preparation containing Brufen arginine codeine |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/05/2006 | USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101911 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 09/05/2006 | US7101905 Pharmaceutically active compounds and methods of use |
| 09/05/2006 | US7101899 N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide; adenosine A3 receptor antagonistic activity |
| 09/05/2006 | US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101866 6,9-Difluoro-17 alpha -((2-furanylcarbonyl)oxy)-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; antiinflammatory agents for the treatment of allergic conditions |
| 09/05/2006 | US7101864 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101856 Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/05/2006 | US7101853 Provided amylin agonist is not calcitonin; also amylin used in combination with an nonsteroidal antiinflammatory agent to relieve pain, thereby achieving a synergistic effect |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101849 ωconotoxin peptides |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 09/05/2006 | CA2412885C Porous celecoxib matrices and methods of manufacture thereof |
| 09/05/2006 | CA2393640C Pyrrolo[2,3-d]pyrimidine compounds |
| 08/31/2006 | WO2006090932A1 Surrogate marker for sulfonamide compound |
| 08/31/2006 | WO2006090921A1 Inhibitory effect of sulfonamide compound on lymphocyte activation |
| 08/31/2006 | WO2006090874A1 Method of analyzing mammalian t cell cytokines, method of evaluating all of related diseases and analysis of prevention and therapy therefor |
| 08/31/2006 | WO2006090853A1 Nitrogenous heterocyclic compound and medicinal use thereof |
| 08/31/2006 | WO2006090848A1 Method for detection of nucleotide polymorphism in gene used for diagnosing effect of methotrexate therapy in rheumatoid arthritis patient |
| 08/31/2006 | WO2006090839A1 Medicine for external application containing anti-inflammatory agent and soy lecithin |
| 08/31/2006 | WO2006090833A1 Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent |
| 08/31/2006 | WO2006090817A1 Indole compound and use thereof |
| 08/31/2006 | WO2006090782A1 Composition for hydrous adhesive patch for external use and adhesive patch comprising the composition |
| 08/31/2006 | WO2006090768A1 Process for production of optically active ppar-activating compound and intermediate of the same |
| 08/31/2006 | WO2006090698A1 Kinase inhibitor and use thereof |
| 08/31/2006 | WO2006090555A1 Akt ACTIVATING AGENT |
| 08/31/2006 | WO2006090234A1 Heterocyclic derivatives as cell adhesion inhibitors |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | WO2006090143A1 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 08/31/2006 | WO2006089881A1 Use of phenanthrene derivatives as anti-inflammatory agents, synthesis method and intermediate products |
| 08/31/2006 | WO2006089798A1 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
| 08/31/2006 | WO2006089700A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | WO2006089549A1 Ykl-40 monoclonal antibodies |
| 08/31/2006 | WO2006050965A8 Pyrimidine compounds as histamine modulators |
| 08/31/2006 | WO2006048862A3 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 08/31/2006 | WO2006035244A3 Ecteinascidin compounds as anti -inflammatory agents |
| 08/31/2006 | US20060194951 Polynucleotides encoding interferon gamma polypeptides |
| 08/31/2006 | US20060194881 Composition comprising at least one alkanolamide to inhibit megration of langerhans cells and uses therof |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194851 Benzofuran compound and medicinal composition containing the same |
| 08/31/2006 | US20060194850 methyl 3-(4-{4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-isoxazolyl}-benzylsulfanyl)propionate; compounds inhibit the physiological activity of lysophosphatidic acid (LPA); treatment of fibrosis of organs (liver, kidney, lung, and the like), hepatic disease |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194847 Novel 6-substituted 2-aminopyridine derivatives |
| 08/31/2006 | US20060194836 Novel compounds having 4-pyridylalkylthio group as substituent |
| 08/31/2006 | US20060194824 Compositions containing pyrimidine derivatives as inhibitors of cox-2 |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194811 Pyrimidine derivatives |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194787 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060194727 Prevention and reduction of blood loss |
| 08/31/2006 | US20060193871 transmission and, or amplification of signal; oral or enteric administering, dissolving, absorption; peptide yy; obesity therapy |
| 08/31/2006 | US20060193833 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 08/31/2006 | US20060193823 Hydrolytically degradable carbamate derivatives of poly (Ethylene Glycol) |
| 08/31/2006 | US20060193790 Promoting whole body health |
| 08/31/2006 | DE102005007468A1 Kovalent gebundene Wirkkomplexe, aus denen Stress-aktivierbare Hautenzyme einen Wirkstoff freisetzen Covalently bound active complexes, from which stress-activated skin enzymes releasing a drug |
| 08/31/2006 | CA2599449A1 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
| 08/31/2006 | CA2599439A1 Ykl-40 monoclonal antibody |
| 08/31/2006 | CA2599348A1 Indole compound and use thereof |
| 08/31/2006 | CA2598943A1 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 08/31/2006 | CA2598853A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | CA2571982A1 Methods of modulating intracellular degradation rates of toxins |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |